GPD1L
Glycerol-3-phosphate dehydrogenase 1-like protein
Also known as: GPD1L_HUMAN, KIAA0089
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q8N335
- Gene
- GPD1L
- Ensembl
- ENSG00000152642
- Chromosome
- 3
- Canonical length
- 351 aa
- Protein class
- Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins
OverviewNCBI Gene
The protein encoded by this gene catalyzes the conversion of sn-glycerol 3-phosphate to glycerone phosphate. The encoded protein is found in the cytoplasm, associated with the plasma membrane, where it binds the sodium channel, voltage-gated, type V, alpha subunit (SCN5A). Defects in this gene are a cause of Brugada syndrome type 2 (BRS2) as well as sudden infant death syndrome (SIDS). [provided by RefSeq, Jul 2010]
Canonical amino-acid sequenceUniProt
351 residues, UniProt reviewed canonical sequence.
>Q8N335|GPD1L
1 MAAAPLKVCI VGSGNWGSAV AKIIGNNVKK LQKFASTVKM WVFEETVNGR KLTDIINNDH
61 ENVKYLPGHK LPENVVAMSN LSEAVQDADL LVFVIPHQFI HRICDEITGR VPKKALGITL
121 IKGIDEGPEG LKLISDIIRE KMGIDISVLM GANIANEVAA EKFCETTIGS KVMENGLLFK
181 ELLQTPNFRI TVVDDADTVE LCGALKNIVA VGAGFCDGLR CGDNTKAAVI RLGLMEMIAF
241 ARIFCKGQVS TATFLESCGV ADLITTCYGG RNRRVAEAFA RTGKTIEELE KEMLNGQKLQ
301 GPQTSAEVYR ILKQKGLLDK FPLFTAVYQI CYESRPVQEM LSCLQSHPEH TLocalizationUniProt · AlphaFold · HPA
Whether an antibody against GPD1L can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.22
- Highest tissue expression
- 237 nTPM
Expression across tissuesHPA
Tissue
- tongue: 237 nTPM
- skeletal muscle: 148 nTPM
- heart muscle: 117 nTPM
- prostate: 56 nTPM
- adrenal gland: 42 nTPM
- blood vessel: 41 nTPM
Single-cell type
- myonuclei: 234 nCPM
- thymic myoid cells: 177 nCPM
- cardiomyocytes: 104 nCPM
- müller glia: 97 nCPM
- choroid plexus epithelial cells: 95 nCPM
- cytotrophoblasts: 95 nCPM
Immune cell
- T-reg: 8.8 nTPM
- MAIT T-cell: 8 nTPM
- NK-cell: 7.4 nTPM
- eosinophil: 5.7 nTPM
- myeloid DC: 5.6 nTPM
- plasmacytoid DC: 4.4 nTPM
Brain region
- choroid plexus: 43 nTPM
- white matter: 31 nTPM
- cerebral cortex: 30 nTPM
- spinal cord: 30 nTPM
- hypothalamus: 29 nTPM
- basal ganglia: 28 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about GPD1L.
Disease | AllUniProt
Conditions GPD1L is implicated in, by any mechanism.
- Brugada syndrome 2 (BRGDA2) MIM:611777
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.7
- gnomAD pLI
- 0.04
- gnomAD missense Z
- 1.08
- DepMap mean gene effect
- 0.1
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- carbohydrate metabolic process
- glycerol-3-phosphate catabolic process
- NAD+ metabolic process
- positive regulation of protein localization to cell surface
- positive regulation of sodium ion transport
- regulation of heart rate
- regulation of ventricular cardiac muscle cell membrane depolarization
- ventricular cardiac muscle cell action potential
Molecular functions
- NAD binding
- oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor
- protein homodimerization activity
- sodium channel regulator activity
- transmembrane transporter binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Glycerol-3-phosphate dehydrogenase, NAD-dependent, C-terminal
- Glycerol-3-phosphate dehydrogenase, NAD-dependent
- 6-phosphogluconate dehydrogenase-like, C-terminal domain superfamily
- Glycerol-3-phosphate dehydrogenase, NAD-dependent, N-terminal
- 6-phosphogluconate dehydrogenase, domain 2
- Glycerol-3-phosphate dehydrogenase, NAD-dependent, eukaryotic
- NAD(P)-binding domain superfamily
- NAD-dependent glycerol-3-phosphate dehydrogenase N-terminus
- NAD-dependent glycerol-3-phosphate dehydrogenase C-terminus
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of GPD1L in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads GPD1L as an antibody target. Whether an autoantibody or antibody against GPD1L could matter depends on whether native GPD1L is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
GPD1L is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label GPD1L as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...